Medical Condition News

RSS

Researchers find way to enhance effects of immunotherapy in glioblastoma

When cancer strikes, it may be possible for patients to fight back with their own defenses, using a strategy known as immunotherapy. According to a new study published in Nature, researchers have found a way to enhance the effects of this therapeutic approach in glioblastoma, a deadly type of brain cancer, and possibly improve patient outcomes.

20 Mar 2015

UZH researchers map spinal cord neurons involved in 'Gate Control Theory' of pain

Sensing pain is extremely unpleasant and sometimes hard to bear - and pain can even become chronic. The perception of pain varies a lot depending on the context in which it is experienced. 50 years ago, neurobiologist Patrick Wall and psychologist Ronald Melzack formulated the so-called "Gate Control Theory" of pain.

20 Mar 2015

Researchers successfully generate cells of immune system to target, destroy cancer cells

Researchers at the Max Delbrück Center for Molecular Medicine Berlin-Buch and Charité - Universitätsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system to specifically target and destroy cancer cells.

20 Mar 2015

New in vitro study examines benefits of pear-enriched diet on chronic diseases

A new in vitro (test tube) study, "Dietary functional benefits of Bartlett and Starkrimson pears for potential management of hyperglycemia, hypertension and ulcer bacteria Helicobacter pylori while supporting beneficial probiotic bacterial response," was published in the March issue of Food Research International.

20 Mar 2015

Visual cues associated with overweight can influence one's sense of smell

Could our reaction to an image of an overweight or obese person affect how we perceive odor? A trio of researchers, including two from UCLA, says yes.

20 Mar 2015

BAI researchers develop new brain image analysis method to better track amyloid changes

Researchers from Banner Alzheimer's Institute have developed a new brain image analysis method to better track the progression of beta-amyloid plaque deposition, a characteristic brain abnormality in Alzheimer's disease, according to a study published in the March issue of the Journal of Nuclear Medicine.

20 Mar 2015

David Cameron obesity benefit proposals “ethically and financially questionable”

The UK Prime Minister’s recent proposal to cut sickness benefit for people who are obese and refuse treatment is ethically and financially flawed, according to an Editorial in The Lancet Diabetes & Endocrinology journal.

19 Mar 2015

Targeted drug doubles progression free survival in Hodgkin lymphoma

A phase 3 trial of brentuximab vedotin (BV), the first new drug for Hodgkin lymphoma in over 30 years, shows that adults with hard-to-treat Hodgkin lymphoma given BV immediately after stem cell transplant survived without the disease progressing for twice as long as those given placebo (43 months vs 24 months).

19 Mar 2015

Vitamin D plays major role in preventing diabetes and atherosclerosis

In recent years, a deficiency of vitamin D has been linked to type 2 diabetes and heart disease, two illnesses that commonly occur together and are the most common cause of illness and death in Western countries. Both disorders are rooted in chronic inflammation, which leads to insulin resistance and the buildup of artery-clogging plaque.

19 Mar 2015

AbbVie signs exclusive worldwide license agreement with C2N for Alzheimer's disease therapies

AbbVie today announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders.

19 Mar 2015

Semler receives 510(k) marketing clearance from FDA for next generation PAD testing system

Semler Scientific, Inc., an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced receipt of 510(k) marketing clearance from the U.S. Food and Drug Administration for its next generation peripheral artery disease (PAD) testing system.

19 Mar 2015

Neurology Times features special coverage of MS in observance of MS Awareness Month

UBM Medica US announces that Neurology Times, a leading online community and information resource for neurologists and other healthcare providers, is featuring special coverage of multiple sclerosis in observance of MS Awareness Month.

19 Mar 2015

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

Pharmacyclics, Inc. today announced that new pre-clinical and clinical data for ibrutinib (IMBRUVICA) will be highlighted at the 2015 American Association for Cancer Research Annual Meeting to be held April 18 – 22, 2015, in Philadelphia, PA.

19 Mar 2015

MTfp-siRNA reduces blood vessel infarct, improves overall brain activity in ischemic stroke model

BIOASIS TECHNOLOGIES INC., a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-‐brain barrier (BBB), announces the results from an animal ischemic stroke model performed at the National Research Council Canada with the biOasis Transcend carrier peptide, MTfp and siRNA (MTfp-‐siRNA).

19 Mar 2015

BCM-95 Curcumin improves chemotherapy's effectiveness in killing chemoresistant cancer cells

Cancer cell resistance to chemotherapy is a major cause of death in patients with colorectal cancer. In a first-of-its-kind study, BCM-95 Curcumin was found to improve chemotherapy's effectiveness in killing chemoresistant cells via a mechanism not previously identified.

19 Mar 2015

Fast-food restaurant ban fails to reduce obesity rates in Los Angeles

A Los Angeles ordinance designed to curb obesity in low-income areas by restricting the opening of new fast-food restaurants has failed to reduce fast-food consumption or reduce obesity rates in the targeted neighborhoods, according to a new RAND Corporation study.

19 Mar 2015

LDLT effective for treating patients suffering from acute liver failure

When patients develop acute liver failure, severe complications arise rapidly after the first signs of liver disease, and patients' health can deteriorate rapidly. New research published in the American Journal of Transplantation indicates that emergency evaluations of living liver donors can be conducted safely to allow acute liver failure patients to undergo transplantation before their condition worsens.

19 Mar 2015

ImmunoCellular, PharmaCell sign manufacturing agreement for European production of ICT-107

ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM).

19 Mar 2015

New diagnostic method replaces surgery for bowel tumor assessment

A new study at the MedUni Vienna's Comprehensive Cancer Center is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.

19 Mar 2015

Cardiac catheterization performed through wrist can reduce bleeding, lower mortality

The groin is the usual access point for investigating or treating the heart with a catheter, but using the wrist as access point reduces bleeding and lowers mortality. These findings are from an international study with major involvement from the University of Bern published today in the Lancet.

19 Mar 2015

Medical Condition News

Researchers find way to enhance effects of immunotherapy in glioblastoma

UZH researchers map spinal cord neurons involved in 'Gate Control Theory' of pain

Researchers successfully generate cells of immune system to target, destroy cancer cells

New in vitro study examines benefits of pear-enriched diet on chronic diseases

Visual cues associated with overweight can influence one's sense of smell

BAI researchers develop new brain image analysis method to better track amyloid changes

David Cameron obesity benefit proposals “ethically and financially questionable”

Targeted drug doubles progression free survival in Hodgkin lymphoma

Vitamin D plays major role in preventing diabetes and atherosclerosis

AbbVie signs exclusive worldwide license agreement with C2N for Alzheimer's disease therapies

Semler receives 510(k) marketing clearance from FDA for next generation PAD testing system

Neurology Times features special coverage of MS in observance of MS Awareness Month

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

MTfp-siRNA reduces blood vessel infarct, improves overall brain activity in ischemic stroke model

BCM-95 Curcumin improves chemotherapy's effectiveness in killing chemoresistant cancer cells

Fast-food restaurant ban fails to reduce obesity rates in Los Angeles

LDLT effective for treating patients suffering from acute liver failure

ImmunoCellular, PharmaCell sign manufacturing agreement for European production of ICT-107

New diagnostic method replaces surgery for bowel tumor assessment

Cardiac catheterization performed through wrist can reduce bleeding, lower mortality

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News